Webinars & Symposia
Stay up to date with the latest developments in research on testing and monitoring for allograft rejection status. Join us at the following events throughout the year.
Missed an event? See our recorded webinars and symposia below.
2020 AUG - SEP
29 - 01
ESOT Congress 2021
Stay tuned for more details about our activities at ESOT.
Innovations in Rejection Surveillance after Heart Transplant
2020 Apr 07
For post-transplant management in heart patients, the endomyocardial biopsy is considered the gold standard to detect acute rejection. However, research has found that in biopsy assessments for rejection, concordance among expert pathologists is less than 67%. In this presentation, Dr. Kobashigawa explores case studies and the clinical use of novel technologies, including molecular diagnostic testing of intragraft mRNA transcripts and donor-derived cell-free DNA, for more accurate diagnosis of cellular and antibody-mediated rejection, acute rejection, and cardiac allograft vasculopathy (CAV).
Shedding Light on the Heart Transplant Biopsy: Use of Intragraft mRNA Transcripts
2020 Sep 09
Webinar featuring guest speakers: Jon A. Kobashigawa MD – Cedars-Sinai Medical Center, Debbie Rinde-Hoffman MD FACC FACP FHFSA – TGH Transplant Institute, and Philip F Hallora MD, PhD – Univeristy of Alberta
Recorded Webinar: MMDx with Philip Halloran
2019 Apr 29
The Molecular Microscope Diagnostic System: Precision and Accuracy in Transplant Diagnostics | Eligible for 1.5 ABHI CECs. To request your CECs, click on the link provided at the end of the video and complete the survey.
Phenotypic diversity of rejection and allograft dysfunction lesson from the Molecular Microscope (MMDx)
2017 Sep 26
Dr. Halloran's presentation at 2017 ESOT features how the MMDx system is used to understand disease states in organ transplants.